Valuation: ResMed, Inc.

Market Cap 30.43B 26.45B 24.62B 22.61B 42.69B 2,905B 43.35B 290B 114B 1,446B 114B 112B 4,849B P/E 2026 *
19.9x
P/E 2027 * 18.6x
Enterprise Value 29.61B 25.74B 23.95B 21.99B 41.53B 2,826B 42.18B 282B 111B 1,407B 111B 109B 4,718B EV / Sales 2026 *
5.24x
EV / Sales 2027 * 4.78x
Free-Float
75.61%
Yield 2026 *
1.15%
Yield 2027 * 1.24%
1 day+1.16%
1 week+8.05%
1 month+8.26%
3 months-1.32%
6 months-18.32%
Current year-12.41%
1 week 195.8
Extreme 195.795
215.2
1 month 190.21
Extreme 190.21
222.43
Current year 180.26
Extreme 180.265
277.67
1 year 180.26
Extreme 180.265
293.81
3 years 132.24
Extreme 132.24
293.81
5 years 132.24
Extreme 132.24
301.34
10 years 56.59
Extreme 56.59
301.34
Manager TitleAgeSince
Chief Executive Officer 53 28/02/2013
Director of Finance/CFO 40 03/05/2026
Compliance Officer - 31/12/2017
Director TitleAgeSince
Director/Board Member 78 31/12/2004
Chairman 53 24/01/2023
Chairman 83 31/05/1989
Date Insider Type Main position Quantity % Market Cap.
07/07/26 Fiscal year

Chief Executive Officer

14,973 0.0103%
09/02/26 Fiscal year

Chief Executive Officer

14,973 0.0103%
04/02/26 Sell

Founder

2,000 0.0014%
Change 5-day change 1-year change 3-year change Capi.($)
+1.16%+8.05%-22.42%-5.11% 30.43B
-0.43%+1.06%+22.80%+4.67% 213B
-0.61%+1.82%-1.11%-23.56% 137B
+0.10%+4.69%-26.56%+8.92% 125B
+1.59%+5.60%-55.46%-9.87% 69.46B
-0.98%+4.16%+8.52%+4.87% 49.56B
-0.91%+5.13%-22.07%-30.22% 47.2B
-0.25%-0.14%+20.52%+13.63% 39.08B
-0.79%+0.70%+30.67%+36.60% 37.05B
-2.75%+12.28%-4.63%-12.79% 30.72B
Average -0.39%+4.29%-4.97%-1.29% 77.88B
Weighted average by Cap. -0.30%+3.23%-2.52%-2.12%

Financials

2026 *2027 *
Net sales 5.65B 4.91B 4.57B 4.2B 7.93B 539B 8.05B 53.9B 21.15B 269B 21.22B 20.76B 901B 6B 5.21B 4.85B 4.45B 8.41B 572B 8.54B 57.19B 22.44B 285B 22.52B 22.02B 955B
Net income 1.55B 1.34B 1.25B 1.15B 2.17B 148B 2.2B 14.75B 5.79B 73.49B 5.81B 5.68B 246B 1.61B 1.4B 1.3B 1.19B 2.26B 153B 2.29B 15.33B 6.02B 76.4B 6.04B 5.91B 256B
Net Debt -827M -719M -669M -614M -1.16B -78.91B -1.18B -7.88B -3.09B -39.29B -3.1B -3.04B -132B -1.74B -1.52B -1.41B -1.29B -2.45B -166B -2.48B -16.63B -6.53B -82.84B -6.55B -6.4B -278B
Logo ResMed, Inc.
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows: - medical devices (51.8%); - masks (35.7%); - software as a service (12.5%): residential care management software solutions. At the end of June 2025, the group had 8 production sites located in the United States (3), Australia, China, Singapore, Malaysia and France. The United States accounts for 63.8% of net sales.
Employees
10,600
Date Price Change Volume
31/07/26 US$210.98 +1.16% 1,113,759
30/07/26 US$208.56 -2.67% 1,091,211
29/07/26 US$214.29 +2.55% 1,325,347
28/07/26 US$208.96 +2.90% 1,137,281
27/07/26 US$203.08 +4.00% 1,142,770
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
210.98USD
Average target price
248.60USD
Spread / Average Target
+17.83%

Quarterly revenue - Rate of surprise